These data suggest that ACE2 attenuates lung cancer metastasis by inhibiting the EMT, and they further indicate that ACE2 may represent a potential therapeutic target in treating lung cancer, where the EMT contributes to the development of tumor metastasis. The gene discussed is ACE2; the disease is neoplasm.